Royal Bank of Canada reissued their outperform rating on shares of Encompass Health (NYSE:EHC – Free Report) in a research note issued to investors on Friday morning, Benzinga reports. They currently have a $83.00 price objective on the stock.
EHC has been the topic of several other reports. Stephens restated an overweight rating and set a $85.00 target price on shares of Encompass Health in a research report on Tuesday, January 16th. William Blair reaffirmed an outperform rating on shares of Encompass Health in a research note on Wednesday, February 7th. Finally, Mizuho raised their price target on Encompass Health from $77.00 to $82.00 and gave the stock a buy rating in a research note on Friday. One investment analyst has rated the stock with a hold rating, seven have given a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of Buy and a consensus target price of $79.89.
Encompass Health Trading Up 0.8 %
Institutional Investors Weigh In On Encompass Health
Large investors have recently made changes to their positions in the company. Principal Securities Inc. bought a new stake in shares of Encompass Health during the 4th quarter worth about $25,000. Benjamin F. Edwards & Company Inc. grew its position in Encompass Health by 360.2% during the fourth quarter. Benjamin F. Edwards & Company Inc. now owns 405 shares of the company’s stock worth $27,000 after buying an additional 317 shares in the last quarter. McGlone Suttner Wealth Management Inc. acquired a new stake in shares of Encompass Health during the 4th quarter valued at about $30,000. GAMMA Investing LLC acquired a new stake in shares of Encompass Health during the 4th quarter valued at about $33,000. Finally, C M Bidwell & Associates Ltd. acquired a new stake in shares of Encompass Health in the 3rd quarter valued at $35,000. Institutional investors own 92.66% of the company’s stock.
About Encompass Health
Encompass Health Corporation provides post-acute healthcare services in the United States. It provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.
- Five stocks we like better than Encompass Health
- Russell 2000 Index, How Investors Use it For Profitable Trading
- 3 attractive stocks that insiders are buying
- How to Evaluate a Stock Before Buying
- Alpha and Omega Semiconductor ready to bounce, DOJ cloud lifts
- With Risk Tolerance, One Size Does Not Fit All
- Wendy’s vs Shake Shack: Out with the new, in with the old?
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.